throbber
CFAD V. Anacor, |PR201 5-01776 ANACOR EX. 2053 - “I/77
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 1/77
`
`

`
`Onychomycosis
`the current approach to diagnosis and therapy
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 2/77
`
`

`
`Robert Baran, MD
`Nail Disease Center.
`Cannes. France
`
`Roderick Hay, MD
`Professor of Cutaneous Medicine
`StJohn's Institute of Dermatology
`StThomas· Hospital
`London. U.K.
`
`Eckart Haneke, MD
`Professor and Director
`Department of Dermatology
`Ferdinand Sauerbruch Hospital
`Wuppertal. Germany
`
`Antonella Tosti, MD
`Associate Professor of Dermatology
`Department of Dermatology
`University of Bologna
`Bologna. Italy
`
`Bianca Maria Piraccini, MD
`Department of Dermatology
`University of Bologna
`Bologna. Italy
`
`Although every effort has been made to ensure that drug
`doses and other Information are presented accurately
`1n this publication. the ult1mate responsibility rests With
`the prescnbing physic1an. Neither the publishers nor the
`authors can be held responsible for errors or for any
`consequences ans1ng from the use of information
`contained herein.
`
`©R. Baran 1999
`
`F1rst published in the United K1ngdom in 1999 by
`Martin Dunitz Ltd.
`The Livery House
`7-9 Pratt Street
`London NW 1 OAE
`
`R epri nted with correcnons 2001
`
`Graphic des1gn by Atelier Hohne. Grafelfing. Germany
`Pnnted and bound 1n Spa1n
`
`All nghts reserved. No part of th1s pubhcauon may be re(cid:173)
`produced. stored 1n a retneval system. or transm1t1ed. 1n any
`form or by any means. electromc. mechanical. photocopying.
`recording or otherWise. Without the pnor permiSSion of the
`publisher or 1n accordance w1th the prov1sions of the
`Copynght Act 19B8. or under the terms of any licence per(cid:173)
`mitting hm1ted copying ISSued by the Copynght L1cens1ng
`Agency. 90 Tottenham Court Road. London W1 P9 HE.
`A CIP catalogue record for this book IS available from the
`Bnt1sh Library
`ISBN 1-85317-767-9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 3/77
`
`

`
`Robert Baran
`Roderick Hay
`Eckart Haneke
`Antonella Tosti
`w ith the collaboration of Bianca Maria Piraccini
`
`Onychomycosis
`the current approach to diagnosis and therapy
`
`Martin Dunitz Ltd.
`Publishers
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 4/77
`
`

`
`Contents
`
`Preface
`
`Epidemiology
`
`2
`
`3
`
`Anatomy of the normal nail
`
`Clinical patterns correlated
`with main routes of entry
`
`4
`
`Clinical differential diagnosis
`
`5
`Mycological examination
`5.1 The proper collection of samples:
`The "How" and "Where"
`5.2 Microscopic examination
`5.3 Culture
`5.4 Histopathological examination
`
`6
`
`Goals for the treatment of onychomycosis
`
`Mycological cure
`
`Clearance of the nail plate
`
`Clinical measurement and assessment
`
`of responses
`
`5 1
`
`6 1
`
`10 I
`
`I
`12 1
`
`20 1
`
`28
`
`28
`30
`31
`34 \
`
`40
`
`40 1
`41
`
`42 1
`
`Review of current antifungal therapy
`
`7
`7.1
`Topical treatment
`7.1.1 Transungual drug delivery systems
`7.1.2 Nail avulsion
`total surgical
`
`partial surgical
`
`chemical
`
`7.2 Systemic treatment w ith new antifungal drugs
`
`ltraconazole
`
`Fluconazole
`
`Terbinaf1ne
`7.3.1 Treatment in the elderly
`7.3.2
`in childhood
`7.3.3
`7.3.4
`in immunocompromised patients
`7.4 Rationale for a stepwise approach to therapy
`
`in pregnant women
`
`8
`Preventive measures
`8.1 Reasons for prevention
`8.1 .1 Genetic predisposition
`8.1.2 Reduced nail growth rate
`8.1 .3 Underlying disease
`8.2. Prevention
`
`Index
`
`44 1
`
`44 1
`
`~I
`:I
`
`50
`54
`54
`
`57 1
`59 ,
`63
`64
`64
`64
`66
`
`70
`70
`
`70 1
`
`~~ I
`
`71 I
`
`73 [
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 5/77
`
`

`
`Preface
`
`This book is w ritten by clinicians for clinicians.
`In it the authors, w ho have an abiding interest
`in all fields of nail pathology, have focused on
`one of the commonest of nail disorders,
`onychomycosis. The stepwise approach provi(cid:173)
`des a basis for identifying the most appropriate
`cost-benefit considerations in the management
`of fungal nail infection. Consideration of the
`subject follows a logical path from clinical
`expression through laboratory diagnosis to
`therapy. The new classification of the clinical
`appearances reflects the underlying nail patho(cid:173)
`logy and provides a rational explanation for the
`pathogenesis and the response to treatment.
`Compared w ith the situat ion ten years ago,
`there is now a wide choice of treatment
`options for patients with onychomycosis from
`topical antifungal agents to nail surgery. The
`development of new treatment regimens.
`however, has had the greatest impact on the
`success of t herapy. This in turn has opened t he
`possibility of successful treatment to the
`majority of patients w ith fungal nail infections.
`particularly those caused by dermatophytes.
`The result has been a major increase in the
`numbers of pat ients with onychomycosis
`presenting for treatment. We hope that this
`book will provide an up to date review of this
`common clinical problem which will be of
`interest to a wide group of health professionals
`including dermatologists, general practitioners.
`practice nurses and chiropodists/ podiatrists.
`
`The authors
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 6/77
`
`

`
`Epidemiology
`
`Onychomycoses are the most common of
`nail diseases. They occur worldwide. but with
`variable frequency depending on different
`climatic. professional and socio-economic
`conditions. One hundred years ago, they were
`considered to be very rare. affecting mainly
`those caring for children with tinea capitis. but
`their prevalence has increased dramatically
`during the last few decades (Table 1.1} [1].
`
`Table 1.1
`Proportion of onychomycoses to dermato(cid:173)
`mycoses (literature survey; from [1])
`
`City and year
`
`Paris
`
`1910
`
`Munich 1913-1922
`
`Berlin
`
`1919- 1934
`
`Munich 1938
`
`Hamburg 1938
`
`Hamburg 1949
`
`Munich 1951
`
`Berlin
`
`1951-1956
`
`Munich 1958
`
`Brussels 1980
`
`%
`
`0.2
`
`0.13
`
`2
`
`2.6
`
`2.8
`
`10
`
`8.4
`
`17.1
`
`11.1
`
`30
`
`Approximately 1.5% to 15% of persons pre(cid:173)
`senting to a dermatologist have onychomycosis
`[2. Klein. pers oral comm]. Other estimates
`suggest between 2% [3] and 23% [4]. There
`are considerable differences in the prevalence:
`a survey of 20.000 persons from North Malawi
`found no onychomycosis though there was a
`1.5 to 2.5% prevalence of dermatophytosis in
`this population [5): this is probably due to the
`fact that many of the people do not wear shoes.
`The frequency of onychomycosis in rural Zaire
`was 0.89%, but 4% of men and 2.8% of
`women in towns had fungal nail infections [6].
`Large scale studies from Europe. the Middle
`East and North America have revealed very
`high rates of fungal nail infections (Table 1.2).
`A prevalence of 27% was found in coal
`miners: heat. humidity and common shower
`facilities were held responsible for this high
`proportion [7]. In another study carried out
`1 0 years later. 327 out of 1000 people from
`the Ruhr area in Germany were found to have a
`dermatophyte infection of their nails [8].
`
`The frequency of onychomycosis increases with
`age. Although these infections are very rare in
`young children- two studies found 0.2 %,
`other studies have failed to find a single case
`and the latest revealed an overall prevalence of
`0.44% [16-20, 51 I- they are common in
`young adults and very common in the elderly
`[ 19]. Among adolescents, young males are
`more frequently affected than females; this is
`probably due to a higher frequency of nail
`damage due to sports and leisure activities
`amongst male adolescents. A recent survey
`among National Basketball Association and
`Women's National Basketball Association
`(WNBA) teams found 89% of the players
`suffered from onychomycosis during their
`career [19a]. A previous survey in Ohio, USA.
`showed that approximately 14% of the general
`population had fungal nail infection and 48% of
`people > 70 years [ 151.
`
`Eighteen to 40% of all nail diseases are due to
`fungal infections [21. 22) and approximately
`30% of all dermatomycoses are nail infections
`[2].
`
`By far the most common pathogens are
`dermatophytes. Virtually unknown in Western
`Europe at the beginning of the 20th century
`Trichophyton rubrum was probably introduced
`from West Africa or Asia and has become the
`most frequent pathogen in Western Europe,
`North America. and Asia causing 50% to 75%
`of all cases of onychomycosis [23. 24].
`T rubrum and T mentagrophytes together
`make up at least 80% of onychomycosis in
`Central Europe [25]. Yeasts can be cultured
`from 5% to 17% of cases w ith >70% of these
`being Candida a/bicans [26]. Non-dermato(cid:173)
`phyte moulds are considered pathogenic in
`less than 5% of cases [25. 27-30] and even
`this proportion is debatable [31]. Seytalidium
`dimidiatum. S. hyalinum and Scopulariopsis
`brevicaulis though are generally accepted as
`nail pathogens as well as some Aspergillus.
`Fusarium. Acremonium spp and Onychoco/a
`canadensis [32]. However. there are con(cid:173)
`siderable variations according to geographical
`location [33]: up to 50% of the onychomycosis
`cases among Thai conscripts were due to
`Scytalidium dimidiatum (Hendersonula
`toruloidea) [34]. In Saudi Arabia. most cases of
`onychomycosis were due to Candida albicans
`with 204 of 243 culturally positive cases of
`onychomycosis and 241 of 257 cases
`secondary to paronychia [35]. However in one
`study 60% of nails that had either been
`
`6
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 7/77
`
`

`
`Table 1.2
`Prevalence of onychomycoses world -wide
`
`Country
`
`Year publ
`
`Prevalence [% ]
`
`Subjects examined
`
`Authors
`
`1965
`Germany
`1966
`Britain
`1966
`East Germany
`1972
`USA
`Germany - Ruhr area 1974
`1977
`Zaire (Congo)
`
`Great Britain
`Spain
`
`Greece
`
`Finland
`
`North Malawi
`Great Britain
`Ontario. Canada
`Ohio. USA
`Canada & USA
`
`1992
`1995
`
`1995
`
`1995
`
`1996
`1996
`1997
`1997
`1997
`
`27
`2
`13
`>15-20
`32.7
`0.9
`2.8
`4.0
`2.7
`2.6
`
`2.5
`11 .7
`8.4
`11 .3
`4.3
`13
`0
`11
`6.9
`14
`0.44
`
`Coal miners
`
`Estimate
`1 000 persons
`rural areas
`urban areas - female
`- male
`omnibus suNey
`computer-ass1sted
`telephone inteNiew system
`fingernails
`toenails
`all ages
`adults
`females
`males
`20.000 rural area
`1 00 diabetics
`
`general population
`2500 children and 50
`adolescents under 18 years
`
`7
`3
`4
`9
`8
`4
`6
`
`10
`11
`
`12
`
`19
`
`5
`13
`14
`15
`20
`
`negative on microscopy or had grown yeasts
`yielded dermatophytes after nail avulsion [36].
`This suggests t hat growth by contaminant
`fungi may obscure the presence of the true
`pathogen. Furthermore. a change in the pattern
`of fungal pathogens has also been noted
`during the last decade [37].
`
`Toenails are about seven times more frequently
`affected than fingernails. The reason for this is
`probably the growth rate which is about three
`times slower for toenails than fingernails [32].
`
`The enormous increase in the prevalence of
`onychomycosis has been attributed to various
`factors. Increased and prolonged exposure to
`fungal pathogens through communal bathing
`and showering facilities. health spas. saunas.
`and gyms. sports activities. wearing of
`occlusive footwear. ageing of the population.
`
`increasing numbers of diabetics. administration
`of immunosuppressive and cytotoxic drugs.
`and the AIDS epidemic are all thought to pre(cid:173)
`dispose to fungal nail infections [38. 39].
`However. a series of investigations from France
`showed that although the main fungal patho(cid:173)
`gen isolated from public sports facilities was
`T mentagrophvtes the fungi isolated from the
`feet of the users were mostly T rubrum [ 40].
`Another study from Wales also did not support
`the assumption that frequent use of public
`changing facilities is necessarily related to the
`transmission of fungal infection. Instead. the
`fact that a high proportion of parents was
`affected suggested that they might act as the
`source of infection [1 7]. Investigations of
`families from Italy. France and the USA suggest
`that susceptibility to fungal nail infections.
`particularly those due to T rubrum. might be
`inherited as an autosomal dominant trait [41 ].
`
`7
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 8/77
`
`

`
`Epidemiology
`
`Damaged nails are more susceptible to
`onychomycoses (3, 42]. This is supported by
`the obseNation that dermatophytes can be
`grown from normal toenails and dermatophyte
`onycholysis of the big toenail may heal after
`correction of an underlying foot deformity
`[43. 44]. Tinea unguium was seen in 42 % of
`subjects with arterial circulatory disorders [45].
`Nail changes alone were seen in 8%. and nail
`and interdigital abnormalities in an additional
`22% of vascular disease patients (controls 4%
`and 0%. respectively). However. cultures were
`positive in only 9% of patients and 1 % of con(cid:173)
`trols [46] (Table 1.3). The role of diabetes melli(cid:173)
`tus is debatable [47]. There may not be an
`increased incidence of dermatophyte infections
`
`of the nail unit in diabetics but Candtda infec(cid:173)
`tions may be more prevalent [48]. However. for
`some authorities [49]. after controlling for age
`and sex. the risk ratio in 55 diabetic subjects for
`onychomycosis of the toes (present in 26.2%
`of the samples) was 2.77 times greater than
`that of normal individuals. The majority of
`organisms implicated in causing onycho(cid:173)
`mycosis were dermatophytes (88%). with
`Candida species in 3% and non-dermatophyte
`moulds accounting for 9% [49].
`
`Psoriasis and hereditary palmoplantar
`keratoses also appear to favour fungal nail
`infections (8, 50-52].
`
`Table 1.3
`Frequency of onychomycoses and importance of predisposing diseases
`
`Condition
`
`Abnormal toenails
`
`Number
`examined
`------
`72
`183
`
`Subungual hyperkeratoses
`
`Podiatric
`
`Impaired arterial circulation
`
`Venous insufficiency
`
`Diabetes mellitus
`
`Psoriasis
`
`Psoriasis
`
`Psoriasis
`
`Psoriasis
`
`Keratosis palmoplantaris
`Old age (> 70 yrs)
`
`168
`
`112
`
`100
`
`100
`
`100
`
`120
`
`78
`
`561
`(298
`(263
`
`8
`
`Onycho-
`mycosis[%)
`
`Reference
`
`3
`
`3
`
`3
`
`43
`
`34
`
`37
`
`42
`
`10 (30)
`
`12 to 26
`
`14
`16
`16
`
`35
`24
`15
`
`27
`23
`30
`
`13
`0.7
`27
`
`48
`
`45
`culture-proven (altered nails) 46
`13 &49
`
`dermatophytes
`Candtda spp
`moulds
`
`all fungi
`dermatophytes
`Candida albicans
`
`all nails in psoriatics
`normal appearing nails
`altered nails
`
`all nails
`normal appearing nails)
`clinically abnormal nails)
`
`8
`
`50
`
`51
`
`14
`
`52
`
`15
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 9/77
`
`

`
`References
`
`1. Haneke E. Epidemiology and
`pathology of onychomycoses. In
`Nolt1ng S. Koning HC. eds. Onychomy(cid:173)
`coses Berlin. Spnnger. 1989:1-8
`2. Achten G. Wanet-Rouard J.
`OnychomycosiS (Mycology No 5).
`Brussels. Cilag: 1 981
`3. Walshe MM. English MP Fungi 1n
`nails Br J Dermatol 1966;
`78.198-207
`4. Seebacher C. Untersuchungen uber
`d1e Pilzflora kranker und gesunder
`Zehennagel. Mykosen 1966:
`11:893-902
`5. Ponn1nghaus JM. Clayton Y.
`Warndorff D The spectrum of derma(cid:173)
`tophytes in northern Malaw1 (Afnca).
`Mycoses 1996: 39:293-297
`6. Vanbreuseghem R. Prevalence des
`onychomycoses au za·,re paniculiere(cid:173)
`ment chez les coupeurs de canne a
`sucre. Ann Soc Belg Med Trop 1977:
`57:7-15
`7. G<itz H. Hantschke D Einblicke 1n
`d1e Ep1dem1olog'e der Dermatol(cid:173)
`mykosen 1m Kohlenbergbau. Hautarzt
`1965. 16:543
`8. G<itz H. Pat1n C. Hantschke D. Das
`Wachstum von Dermatophyten auf
`normalem und psoriatischem Nagel(cid:173)
`keratln. Mykosen 1974: 17:373-377
`9. Zaias N. OnychomycosiS. Arch
`Dermatol 1972: 105:263
`1 0. Robens DT. Prevalence of
`dermatophyte onychomycosis 1n the
`Un1ted Kingdom: results of an omm(cid:173)
`bus survey. Br J Dermatol 1992: 126
`Suppl 39:23-27
`11. Sa is G. Jucgla A. Peyri J. Pre(cid:173)
`valence of dermatophyte onychomy(cid:173)
`COSIS in Spain: a cross-sect1onal study
`Br J Dermatol 1995: 132:758-61
`I 2. Devllotou-Panagiotldou D. Koussl(cid:173)
`dou-Eremondi T. Badillet G. Dermato(cid:173)
`phytosis 1n nonhern Greece during the
`decade 1981-1990. Mycoses 1995;
`38:151-157
`13. Buxton PK. Milne UR. Prescott RJ.
`Proud foots MC: Stuart FM. The pre(cid:173)
`valence of dermatophyte 1nfect1on 1n
`well-controlled diabetiCS and the
`response to Trichophyton ant1gens.
`Br J Dermatol 1996: 134:900-903
`14. Gupta AK. Lynde CW. Jain HC.
`S1bbald RG. Elewski BE. Daniel CR Ill.
`Watteel GN. Summerbell RC. A h1gher
`prevalence of onychomycosiS 1n
`psoriatics compared with non-pso(cid:173)
`natiCS. a multicentre study. Br J
`Dermatol 1997; 136:786-789
`15. Elewski B & Chanf MA. Prevalence
`of onychomycoSIS 1n patients
`attendmg a dermatology cl1nic 1n
`nonheastern Oh1o for other condit1ons
`Arch Dermatol 1997; 133
`1172-1173
`16. Findlay GH. Vismar HF. Soph1anos
`T Spectrum of paed1atnc dermatology.
`Br J Dermatol 1974; 91 :379-387
`17. Philpot CM. Shuttlewonh D. Der(cid:173)
`matophyte onychomycoSIS in children.
`Clln Exp Dermatol1989; 14:203-205
`
`18. Khosravi AR. Aghamman MR.
`Mahmoud1 M. Dermatophytoses 1n
`Iran. Mycoses 1994; 37:43-48
`19. He1kkllii H. Stubb S The pre(cid:173)
`valence of onychomycosis in F1nland
`Br J Dermatol 1995; 133:699- 703
`19a. McNerney J. OnychomycOSIS 1n
`spec1al populations ISS02-05). JEADV
`2000; 14 (suppl 14). 83.
`20. Gupta AK. Sibbald RG. Lynde CD.
`Hull PR. Shear NH. de Doncker P.
`Dan1el CRIll. OnychomycosiS 1n
`children: prevalence and treatment
`strategies JAm Acad Dermatol 1997;
`36:395-402
`2 1. Langer H. Ep1demiolog1sche
`und klinische Untersuchungen be1
`Onychomykosen. Arch Kiln Exp
`Dermatol1957; 204.624
`22. Achten G. Wanet-Rouard J.
`Onychomycoses 1n the laboratory.
`Mykosen 1978; 23. Suppl 1.125
`23. Darde ML. Ep,dem1olog'e des
`dermatophyt1es. Ann Dermatol
`Venereol 1992: 119:99-100
`24. Manzano-Gayosso P. Mendez(cid:173)
`Tovar U. H~rnandez- Hernandez F.
`L6pez-Manlnez R Dermatophytoses
`1n Mex1co City. Mycoses 1994;
`37:49-52
`25. Clayton YM. Clin1cal and mycolo(cid:173)
`gical diagnostic aspects of onychomy(cid:173)
`coses and dermatomycoses. Clin Exp
`Dermatol 1992; 17: suppl 1 :37-40
`26. Cohen J. Scher RK. Pappert A.
`The nail and fungus infections.
`In Elewsk1 B. ed. Cutaneous Fungal
`lnfect1ons. New York. lgaku Sho1n.
`1992:106-123
`27. Summerbell RC. Kane J. Krajden S.
`Onychomycosis. t1nea ped1s. and tinea
`manuum caused by non-dermato(cid:173)
`phytiC filamentous fung1. Mycoses
`1989; 32:609-619
`28. Willemsen MD. Changing pattern
`in superficial 1nfect1ons: focus on
`onychomycOSIS. J Eur Acad Dermatol
`Venereal 1993; 2:S6- S11
`29. Williams HC The ep1dem1ology
`of onychomycosiS 1n Bnta1n. Br J
`Dermatol 1993; 129:101-109
`30. Greer DL. Et1ology of onycho(cid:173)
`mycosis: rev1ew of the literature.
`Issues 1n the modern management of
`onychomycosis. Monte Carlo 1993
`31. Ell1s DH. Watson AB. Marley JE.
`Williams TG. Non-dermatophytes 1n
`onychomycosis of the toena1ls. Br J
`Derma to I 1997. 136.490-493
`32. Haneke E. Fungal 1nfect1ons of the
`na1l. Sem Dermatol 1991 . 1 0: 41-53
`33. Elewsk1 BE. Hay RJ. Update on
`the management of onychomycosis.
`Highlights of the Third Annual
`International Summ1t of Cutaneous
`Ant1fungal Therapy Clin lnf D1s 1996;
`23:305-313
`34. Kotrawas R. Chongsathe1n S.
`Rojanavamch V. Buddhavudh1kara1 P.
`Vinyayadhakorn S Hendersonula
`toruloidea mfect1on 1n Tha1land. lnt J
`Dermatol 1988; 27:391-395
`35. AI-Sogair SM. Moawad MK.
`AI-Humaidan YM. Fungalmfectlon as
`a cause of skin d1sease 1n the Eastern
`Province of Saudi Arabia: prevailing
`fung1 and pattern of infectiOn
`Mycoses 1991. 34 :333-337
`
`36. Sz11i M. Sandor L. Comparative
`mycolog1cal stud1es from nails
`removed because of onychomyCOSIS
`(Hunganan). B<irgy6gy Venerol Szle
`1984; 60:175-177
`37. G1nter G. R1eger E. He1gl K.
`Propst E. Ste1gend~ Hauf1gke1t der
`Onychomykose - Andert s1ch das
`Erregerspektrum? Mycoses 1996: 39
`Suppl 1·118-122
`38. Barranco V New approaches to
`the d1agnosis and management of
`onychomycosis. lnt J Dermatol 1994;
`33:292-299
`39. Conant MA. The AIDS ep1dem1c
`J Am Acad Dermatol 1 994; 31
`Suppi:S47-S50
`40. FeUIIhade M. Pied et mycoses
`Aspects epidemiOIOglques Pled 1990:
`6:5-6
`4 1. Za1as N. Tosti A. Rebell G. Morelli
`R. Bardaw F. B1eley H. Za1ac M. Glick
`B. Paley B; Allevato M. Baran R.
`Autosomal dom1nant pattern of distal
`subungual onychomycOSIS caused by
`Tnchophyton rubrum J Am Acad
`Dermatol 1996; 34:302-304
`42. Male 0. Tappeiner J. Nagelver(cid:173)
`anderungen durch Schimmelpilze
`Dermatol Wschr 1965; 151-212
`43. Baran R. Bad1llet G. Un dermato(cid:173)
`phyte ungueal est-11 necessa1rement
`pathogene? Ann Dermatol Venererol
`1983; 110:629-631
`44. Baran R. Badillet G. Pnmary
`onycholysis of the b1g toenail: a review
`of 112 cases. Br J Dermatol 1982;
`106:529- 534
`45. Dahlke H. Zur Pathogenese der
`Tinea pedis. Insbesondere be1 pen(cid:173)
`pheren Durchblutungsst<irungen
`Mykosen 1971; 14:409-413
`46. Wienert V. Stemmer R.
`Onychomykosen be1 phlebolog1schen
`Patienten. Phlebol Proktol 1982:
`11:281-283
`47. Buxton PK, Milne UR. Prescott RJ
`et al .. The prevalence of dermatophyte
`1nfect1on 1n well-controlled diabetiCS
`and the response to Tnchophyton
`antigen. Br J Dermatol. 1996: 134.
`900-903
`48. R1ch P. Special patient populations.
`onychomycosiS in the d1abet1c pat1ent.
`JAm Acad Dermatol. 1996;
`35:S10-S12
`49. Gupta AK. Konmkof N. Mac
`Donald P et al. Prevalence and ep1·
`derm1ology of toenail onychomycosis
`in d1abetic subjects: a mult1centre
`survey. Br J Dermatol 1998: 139:
`665-671
`50. Feuerman E. Alteras I. Aryelly J.
`The 1ncidence of pathogenic fung1 1n
`psonatic na1ls. Castellama 1976;
`4:195-196
`5 1. Staberg B. Gammeltoft MD.
`Onsberg P. OnychomycosiS 1n pat1ents
`w1th psonas1s Acta Dermatol Venereol
`1983;63:436-438
`52. Nielsen PG. Faergemann J.
`Dermatophytes and keratin 1n patients
`w1th hereditary palmoplanta r kerato(cid:173)
`derma Acta Dermatol Venereol 1993;
`73:416-418
`
`9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 10/77
`
`

`
`L
`
`Anatomy of the normal nail
`
`The nail unit lies immediately above the peri(cid:173)
`ostium of the distal phalanx and consists of a
`keratinized product. the nail plate. and four
`specialized epithelia : the proximal nail fold (or
`eponychium). the nail matrix. the nail bed and
`the hyponychium (Fig 2.1) (1. 2].
`
`The proximal part of the fingernails. especially
`the thumbs. shows a whitish. opaque. half(cid:173)
`moon-shaped area. the lunula. which is the
`visible portion of the nail matrix. The shape of
`the lunula determines the shape of the free
`edge of the nail plate.
`
`Nail plate
`
`The nail plate is a fully keratinized multilayered
`sheet of cornified cells. From the 15th week of
`embryonic life. nail plate production occurs
`cont inuously and thereafter almost uniformly
`throughout life [1]. The nail plate is almost
`rectangular in shape and translucent. It appears
`pink because of the blood vessels of the under(cid:173)
`lying nail bed. The nail plate adheres tightly to
`the nail bed. since the horny layer of the nail bed
`partially contributes to the formation of the ven(cid:173)
`tral nail plate [3]. The nail plate has a somewhat
`loose attachment. along its lateral borders [4].
`
`Fig 2.1
`Sagittal section
`through fingernail
`
`Transverse section
`throug h fi ngernail
`
`Proximally and laterally, the nail plate is
`surrounded by the proximal and lateral folds.
`whereas its distal margin is free. Detachment of
`the nail plate from the underlying tissues occurs
`at the hyponychium. which marks the separa(cid:173)
`tion of the nail from the digit. The nail plate's
`free edge appears white due the presence of
`air in the subungual space.This space frequent(cid:173)
`ly contains keratinous debris. especially in the
`toenails.
`
`10
`
`More than 90% of fingernails show a thin distal
`transverse white band. the onychocorneal
`band. which marks the most distal portion of
`firm attachment of the nail plate to the nail bed
`[5]. This area represents an important anatomi(cid:173)
`cal barrier against environmental and microbial
`hazards.
`
`In transverse sections. the nail plate consists
`of three portions: dorsal nail plate. intermediate
`nail plate and ventral nail plate [6]. The dorsal
`and intermediate portions of the nail plate are
`produced by the nail matrix and consist of hard
`keratins. The intermediate nail plate. w hich is
`produced by the distal matrix. represents 2iJ of
`the whole nail thickness. The ventral portion of
`the nail plate is produced by the nail bed and is
`formed by soft keratins. The thickness of this
`portion of the nail plate considerably increases
`in nail bed disorders.
`
`Nail matrix
`
`The nail matrix consists of a proliferative
`epithelium that keratinizes in the absence of a
`granular layer. Maturation and differentiation of
`nail matrix keratinocytes lead to the formation
`of the superficial and intermediate layers of the
`nail plate. The site of nail matrix keratinization
`can be recognized in histological sections as an
`eosinophilic band (keratogenous zone). In this
`area. nail matrix keratinocytes show nuclear
`fragmentation and condensation of cytoplasm.
`
`In longitudinal sections the matrix consists of
`a proximal (dorsal) and a distal (ventral) region.
`Proximal nail matrix keratinocytes give rise to
`the upper portion of the nail plate whereas
`distal nail matrix keratinocytes produce its inter(cid:173)
`mediate portion.
`
`The nail matrix epithelium contains melano(cid:173)
`cytes. Although nail matrix melanocytes are
`usually quiescent. they may start to produce
`melanin in a large number of physiological and
`pathological conditions. This is more common
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 11/77
`
`

`
`in Black and Asian populations than 1n Caucasi(cid:173)
`ans. The nail growth rates range from 1 .8 to
`4.8 mm/ month in fingernails and 1 .3 to 1 .8
`mm/month in toenails. This gradually declines
`with age [7]. Complete replacement of a finger(cid:173)
`nail requires 4 to 6 months and that of a toenail
`12 to 18 months. Linear nail growth may also
`increase in some physiological and pathological
`circumstances and may be influenced by
`drugs. The triazole derivatives itraconazole [8)
`and fluconazole [9) have been reported to
`enhance nail growth. Terbinafine may also
`induce an increase of linear nail growth [1 0].
`
`Hyponychium
`
`The hyponychium is normally covered by the
`nail plate's free margin, but becomes visible in
`nail biters or when the nail plate is cut very
`short.
`
`Its epithelium is similar to that of plantar or volar
`skin and it keratinizes through the formation of
`a granular layer. Cornified hyponychial cells
`accumulate in the subungual space. especially
`in toenails.
`
`Nail bed
`
`Proximal nail fold
`
`The nail bed epithelium consists of several cell
`layers and extends from the lunula to the
`hyponychium. Nail bed keratinization occurs in
`the absence of a granular layer and gives rise
`to the ventral nail plate. This corresponds to
`about Ys of the terminal nail thickness and it can
`be recognized in histological sections because
`of its mild eosinophilia.
`
`The nail bed dermoepidermal architecture
`shows a distinctive arrangement w ith longi(cid:173)
`tudinal grooves and ridges extending from the
`lunula to the hyponychium. The nail bed
`capillaries run longitudinally along these nail
`bed grooves.
`
`The nail bed epithelium is so adherent to the
`nail plate that it remains attached to the under(cid:173)
`surface of the nail when this is avulsed.
`
`The proximal nail plate is surrounded and
`partially covered by the proximal nail fold.
`which overlies about a quarter of the nail plate.
`Adhesion between proximal nail fold and nail
`plate is tight due to the presence of the cuticle.
`which is firmly attached to the superficial nail
`plate. The cuticle. which is continuously formed
`by keratinization of the proximal nail plate.
`consists of a thin layer of orthokeratotic cells.
`
`The proximal nail fold consists of a dorsal
`portion that is anatomically similar to the skin
`of the dorsum of the digit and a ventral portion
`that continues proximally w ith the proximal
`matrix.
`
`References
`
`1. Za1as N. The nail 1n health and
`d1sease. 2nd ed. Appleton & Lange.
`Norwalk. 1990
`2. Baran R. Dawber RPR. D1sease
`of the nails and their management
`Blackwell. Oxford. 1994
`3. Johnson M. Cosma1sh JS. Shuster
`S Na1l IS produced by the normal nail
`bed a controversy resolved Br J
`Dermatol. 1991, 125:27-29
`
`4. Baran R. De Doncker P. Lateral edge
`Involvement 1nd1cates poor prognos1s
`for treat1ng onychomycosis w1th the
`new system1c anufungals. Acta Derm
`Venereal 1996. 73 : 82-83
`5. Sonnex TS. Gnfflths WAD. N1col
`WJ. The nature and s1gn1f1cance of the
`transverse w hite band of human na1ls.
`Sem1nars Dermatol. 1981. 10: 12- 1 6
`6. Forslind B. B1ophyS1Cal stud1es of
`the normal nail Acta Derm Venereal
`1970; 50 161-168.
`7. Bean WB. Na1l growth. Twenty-f1ve
`year's obseNation. Arch Intern Med
`1968, 122. 359-361
`
`8. De Doncker P. P1erard G. Acqwed
`nad beading 1n patients rece1ving
`1traconazole An mdicator of faster na1l
`growth ? A study us1ng opt1cal profdo(cid:173)
`metry. Clin Exp Derm. 1994, 19.
`404- 406.
`9. Shelley WB. Shelley ED. Ponra1t of a
`practice. Cutis 1992: 49. 386.
`10. Faergemann J. Anderson C. Hersle
`K et al. Double-blind. parallel-group
`cornpanson of terbinaf1ne and gnseo(cid:173)
`fulvln 1n the treatment of toena1l
`onychomycosis. J Am Acad Dermatol
`1995: 32: 750-753.
`
`11
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 12/77
`
`

`
`r )
`\.. )
`
`Clinical patterns correlated
`with main routes of entry
`
`Fig 3.1
`Distal lateral subung ual onychomycosis
`
`Fig 3.2
`DLSO due to T. rubrum
`
`Fig 3.3
`DLSO w ith onycholysis due to T. rubrum
`
`A fungus gains entry to the nail by four main
`routes. each resulting in different clinical
`patterns of infection [1-2]. These are :
`
`• Via the distal subungual area and the
`lateral nail groove (Fig 3.1) leading to distal
`lateral subungual onychomycosis (DLSO)
`(Fig 3.2). The fungus invades the horny layer of
`the hyponychium and/or the nail bed. then the
`undersurface of the nail plate which becomes
`opaque. This causes thickening of the horny
`layer raising the free edge of the nail plate with
`disruption of the normal nail plate-nail bed
`attachment. The disease spreads proximally
`against the stream of nail growth. Sometimes
`a yellow brown discoloration is observed.
`T. rubrum is the most common fungal invader.
`T. mentagrophytes var. interdigitale is much
`less common and Eptdermophyton floccosum
`is rare. In contrast to this form. DLSO may also
`appear as primary onycholysis with a minimum
`of hyperkeratosis especially in fingernails
`(Fig 3.3). Primary onycholysis may be associ(cid:173)
`ated w ith the presence of Candtda (Fig 3.4).
`Overriding of the toes and repeated micro(cid:173)
`trauma of the nail against the shoes may create
`an area of onycholysis favourable to the invasion
`of microorganisms. In such cases. mixed infec(cid:173)
`tion due to T rubrum and Pseudomonas is not
`exceptional (Fig 3.5).The clinical significance of
`nail invasion or colonization by fungi which are
`not normally pathogenic needs to be carefully
`considered in the light of laboratory findings.
`
`The nail bed infection in DLSO caused by
`T rubrum is the result of the fungus spreading
`from the plantar (Fig 3.6) [3] and palmar sur(cid:173)
`face of the feet and hands. a pattern seen in
`the one-hand/two-foot tinea syndrome
`(Fig 3.7) [4].
`
`T mentagrophytes var. mterdigitale produces
`a chronic syndrome with episodic pruritic
`vesicles in the skin of the plantar arch and in
`the toewebs w here scaling is also visible.
`Intermittent vesicles. scaling of the heel and
`thickening of the skin of the sole are often
`visible. This syndrome can also be observed in
`patients with superficial white onychomycosis
`caused by the same fungus. Organisms such
`as Scytaltdium dimidiatum which mimic the
`pattern of disease caused by dermatophytes
`produce the clinical pattern of DLSO but this is
`often associated with onycholysis and. some(cid:173)
`times. paronychia in fingernails (Fig 3.8).
`
`12
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 13/77
`
`

`
`Fig 3.4
`Candida onycholysis
`
`Fig 3.7
`One-hand/ two-foot syndrome
`
`Fig 3.5
`Mixed infection due to T. rubrum
`and Pseudomonas
`
`Fig 3.8
`DLSO due to Scyta/idium dimidiatum
`w ith associated paronychia
`
`Fig 3.6
`Tinea pedis
`
`13
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2053 - 14/77
`
`

`
`Clinical patterns correlated
`with main routes of entry
`
`• Via the dorsal surface of the nail plate
`(Fig 3.9). producing superticial onychomycosis
`(SO) (Fig 3.1 0). Superticial white onycho(cid:173)
`mycosis (SWO) is normally confined to the
`toenails. The causative organisms produce the
`clinical picture of small. w hite patches with
`distinct edges

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket